Literature DB >> 10657465

Understanding corticotropin releasing factor neurobiology: contributions from mutant mice.

A Contarino1, S C Heinrichs, L H Gold.   

Abstract

Mice with transgenic expression or deletion of the CRF peptide, transgenic expression of the CRF-BP or deletion of specific CRF receptor subtypes exist and will be valuable for examining candidate mediators in animal model systems recapitulating a variety of normal function. In particular, results described in this review implicate CRF in acute emotional responses studied in animal models of anxiety and drug abstinence. CRF also appears to play a role in behavioral and physiological plasticity judging by alterations in HPA reactivity to stress, information processing and energy balance regulation in CRF mutant models. Accordingly, the creation of genetically engineered mice now permits the evaluation of contributory roles for several CRF-related gene products in the pathophysiology of a variety of complex behavioral disorders. For example, the postulated causal linkage between overactivation of CRF systems and the hyper-emotionality which characterizes human affective disorders can now be more thoroughly evaluated by examining the phenotype of CRF mutant mice in animal models of depression, dementia and substance abuse.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10657465     DOI: 10.1054/npep.1999.0001

Source DB:  PubMed          Journal:  Neuropeptides        ISSN: 0143-4179            Impact factor:   3.286


  4 in total

1.  Extrahypothalamic corticoliberin receptors regulate the reinforcing effects of self-stimulation.

Authors:  P D Shabanov; A A Lebedev; A D Nozdrachev
Journal:  Dokl Biol Sci       Date:  2006 Jan-Feb

2.  Evaluation of an anxiety-related phenotype in galanin overexpressing transgenic mice.

Authors:  Andrew Holmes; Rebecca J Yang; Jacqueline N Crawley
Journal:  J Mol Neurosci       Date:  2002 Feb-Apr       Impact factor: 3.444

Review 3.  Synaptic physiology of central CRH system.

Authors:  Joel P Gallagher; Luis F Orozco-Cabal; Jie Liu; Patricia Shinnick-Gallagher
Journal:  Eur J Pharmacol       Date:  2008-02-01       Impact factor: 4.432

Review 4.  Corticotropin releasing factor-binding protein (CRF-BP) as a potential new therapeutic target in Alzheimer's disease and stress disorders.

Authors:  Dorien Vandael; Natalia V Gounko
Journal:  Transl Psychiatry       Date:  2019-10-22       Impact factor: 6.222

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.